Zimbabwe has rejected a major American health deal valued at $367m (£272m) spanning five years due to the United States' insistence on confidential biological samples.
The decision became public following a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson later stated that the United States was requesting health data for scientific study and commercial gain but was not willing to share the benefits from future treatments.
"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued talks to find a agreement acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Background
This development comes after a comparable situation in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
Based on statements, 16 African countries have so far signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Effectively, our country would supply the raw materials for medical research with no assurance that the end products would be accessible to our population should a future health crisis emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures previously set up through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to manage future global health emergencies.
"This framework is intended to ensure that when a country provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued discussions with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but recommended that talks should continue considering a large portion of the country's HIV programmes were funded by external financing.
"Where specific concerns arise, including those involving data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.
The halted deal highlights the continuing challenges between receiving vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.